Timothy syndrome is a rare but serious genetic disorder caused by a small change in a calcium channel - a part of our cells that helps control how messages are passed in the body. This syndrome can disrupt the way the heart beats, brain development, and how neurons (brain cells) can communicate with one another. The most notable effect of Timothy syndrome is on the heart; hence, its neurological symptoms are often overlooked.
One of the key factors contributing to the neurological symptoms is a mutation (change) in the CACNA1C gene. This change affects calcium signalling, which is essential for brain development and proper communication between brain cells. This alteration helps explain the neurological symptoms observed in conditions such as:
- Autism Spectrum Disorder (ASD)
- Seizures
- Learning difficulties
Understanding the science behind these neurological features can unlock better treatment approaches and provide a sense of support and understanding if you or someone you know is affected by this condition.
Introduction
Timothy syndrome is a rare and serious genetic disorder that affects the heart, fingers, toes, and nervous system. It is caused by a change in the CACNA1C gene, which controls calcium channels. These channels help send signals in the brain and control muscles, such as those in the heart and blood vessels.1 When the channels don't work properly, it causes problems with the heart rhythm, the development of the brain, and how the brain communicates with itself and the body.
The vast majority (about 80%) of deaths that arise from Timothy syndrome occur due to the heart problems that are associated with it.
Timothy syndrome was first identified when a group of children were found to have shared symptoms of fused or webbed fingers, abnormal heart rhythms, and neurological issues. When these children were genetically tested, a mutation in the CACNA1C gene was found, and the syndrome was officially recognised.2 This article will explore the neurological features of Timothy syndrome and explain what causes them.
Genetics of Timothy syndrome
Mutations in the CACNA1C gene can give rise to two different subtypes of Timothy syndrome, depending on the exact location of the change. These are (classical) type 1 Timothy syndrome and (atypical) type 2 Timothy syndrome. As the names suggest, type 1 is more common than type 2.3
Timothy syndrome is considered to be autosomal dominant, meaning that even if only one of the parents carries the mutated form of the gene, their child can inherit the syndrome.
Neurological basis of Timothy syndrome
To understand how the neurological features of Timothy syndrome arise, we must first address how a mutation in calcium channels can lead to neurological symptoms. The type of calcium channels that are produced by the CACNA1C gene are called Cav1.2 channels and are mainly present in the heart and the brain. In the brain, these channels are involved in processes such as drug addiction, memory, learning, and brain development.4
A bit more about Cav1.2 channels in the brain
Signals in the brain are transmitted via electricity. This electricity must be closely monitored by a network of ion channels that either boost or dampen the signals. These prevent the brain cells from firing too much (like in epilepsy) or too little (leading them to die). Cav1.2 channels open in response to electrical signals from other neurons; therefore, they are called “voltage-dependent”. When these channels get activated, it allows calcium to flow into the neuron, hence turning the channel “on”. Calcium ions are essential in cellular processes, including the transmission of signals across the gaps between two brain cells, where electrical signals are temporarily converted into chemical messages (neurotransmitters) that trigger electrical activity in the next cell.
As Cav1.2 channels are voltage-dependent, they also rely on the cell voltage to turn “off” or close, ensuring that the signalling remains precise and the information passed along is clear.
Cav1.2 in Timothy syndrome
In Timothy syndrome, the switching “off” mechanism is impaired, causing a calcium overload, wherever the Cav1.2 channel is present.5 This information, in combination with the fact that correct calcium signalling is vital for healthy brain development, could explain the basis of the neurological features of Timothy syndrome.6 In simple terms, Cav1.2 dysfunction in Timothy syndrome is characterised by:
- Disrupted brain development, causing developmental conditions like autism spectrum disorder
- Overactive or misfiring neurons, leading to seizures
- Impaired learning and memory, resulting in intellectual disabilities
We will dive into the individual disorders and how they arise due to Timothy syndrome below.
ASD in Timothy syndrome
Prevalence & symptoms
Due to how rare Timothy syndrome is, it is difficult for researchers to estimate how many people with the condition also have autism spectrum disorder. However, studies using model organisms suggest that the vast majority of those with the mutation responsible for Timothy syndrome develop autism spectrum-like behaviours.7 These behaviours may include:
- Difficulties with communication - for example, trouble with eye contact, understanding social cues, and responding to their name
- Repetitive behaviours - for example, self-stimulatory actions (stimming) and rigid routines
- Sensory processing issues - for example, extreme reactions to certain tastes, smells, or textures
Neurological basis
Autism neurobiology is very complex and not yet fully understood. With this being said, ASD has been previously associated with genetic changes in voltage-dependent calcium channels as well as faulty calcium signalling more generally.8,9 These changes in calcium signalling can give rise to the differences in brain cell signalling that are responsible for the symptoms of autism spectrum disorder.
Seizures in Timothy syndrome
The neurobiology of seizures in Timothy syndrome is relatively straightforward. The mutation responsible for Timothy syndrome is responsible for allowing too many calcium ions into cells. This may result in reduced control over the firing and signalling of brain cells. Limited inhibition of neuronal activity is directly responsible for causing seizures. Studies have found the prevalence of seizures in about a third of people with type 1 Timothy syndrome and over 70% of those with type 2 Timothy syndrome.10
Intellectual disabilities in Timothy syndrome
The prevalence and severity of intellectual disabilities and learning issues in those with Timothy syndrome are highly dependent on the type of mutation involved.10 The number of children with Timothy syndrome in education is low, and most experience some level of developmental delays, including:10
- Limited reading levels
- Difficulty with numerical or computational skills
- Delays or difficulty with learning the alphabet
- Attention deficits
Neurobiological basis
Research suggests that mutations in Cav1.2 channels in Timothy syndrome can cause stunted growth of neurons, leading them to branch less or signal differently. This, in turn leads to stunted brain development, hence may explain the intellectual disabilities seen in those with Timothy syndrome.11
Current and future treatment approaches
Support for ASD Symptoms
At present, there are no medications specifically designed to treat autism spectrum disorder. Since the needs of individuals with ASD can vary from individual to individual, however, certain individuals may benefit from different therapies and interventions like:
- Behavioural management therapy
- Cognitive behavioural therapy
- Occupational therapy
- Social skills training
- Speech-language therapy
Managing seizures
Seizures are usually managed using anti-epileptic drugs, epilepsy surgery or dietary changes. However, there is limited information on the effectiveness of anti-epileptic drugs for Timothy syndrome.
Addressing cognitive impairment
The needs of those with cognitive impairments and intellectual disabilities can vary greatly from person to person. It is important to tailor treatment to the needs of an individual. There are specific interventions that can help to support someone with such additional needs. These include:12
- Specialised educational plans
- Training for carers
- Early intervention to identify and address individual needs
- Treating any other conditions that may be present to ensure comfort and support
Future prospects
Currently, there are no treatments for Timothy syndrome in development. However, researchers are exploring possible gene therapy as a future treatment for this syndrome. This approach aims to correct the mutation in the CACNA1C gene that is responsible for Timothy syndrome.
Summary
Timothy syndrome is an extremely rare and severe genetic disorder that affects the heart, limbs, and nervous system. It is caused by a genetic mutation that leads to faulty calcium channels. Neurologically, Timothy syndrome is linked to ASD, seizures and intellectual disabilities, all of which result from disrupted calcium signalling in the brain. While there is currently no cure for the syndrome, ongoing research into gene therapy and targeted drug treatments offers hope for better management in the future. Early diagnosis and individualised care plans are essential to improve the quality of life of those affected.
References
- Wei Y, Yu Z, Wang L, Li X, Li N, Bai Q, et al. Structural bases of inhibitory mechanism of CaV1.2 channel inhibitors. Nat Commun. 2024; 15(1):2772. Available from: https://www.nature.com/articles/s41467-024-47116-8.
- Bauer R, Timothy KW, Golden A. Update on the Molecular Genetics of Timothy Syndrome. Front Pediatr. 2021; 9. Available from: https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2021.668546/full.
- Hiippala A, Tallila J, Myllykangas S, Koskenvuo JW, Alastalo T. Expanding the phenotype of Timothy syndrome type 2: An adolescent with ventricular fibrillation but normal development. American J of Med Genetics Pt A [Internet]. 2015 [cited 2025 Jul 10]; 167(3):629–34. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.36924.
- Li Y, Yang H, He T, Zhang L, Liu C. Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases. Front Pharmacol. 2022; 12:775087. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802068/.
- Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism. Cell [Internet]. 2004 [cited 2025 Jul 10]; 119(1):19–31. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0092867404008426.
- Lohmann C. Calcium signaling and the development of specific neuronal connections. In: Verhaagen J, Hol EM, Huitenga I, Wijnholds J, Bergen AB, Boer GJ, et al., editors. Progress in Brain Research. Elsevier; 2009; bk. 175, p. 443–52. Available from: https://www.sciencedirect.com/science/article/pii/S0079612309175295.
- Bett GCL, Lis A, Wersinger SR, Baizer JS, Duffey ME, Rasmusson RL. A Mouse Model of Timothy Syndrome: a Complex Autistic Disorder Resulting from a Point Mutation in Cav1.2. N Am J Med Sci (Boston). 2012; 5(3):135–40. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872133/.
- Despang P, Salamon S, Breitenkamp A, Kuzmenkina E, Matthes J. Inhibitory effects on L- and N-type calcium channels by a novel CaVβ1 variant identified in a patient with autism spectrum disorder. Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(4):459–70. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873119/.
- Nguyen RL, Medvedeva YV, Ayyagari TE, Schmunk G, Gargus JJ. Intracellular calcium dysregulation in autism spectrum disorder: An analysis of converging organelle signaling pathways. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2018; 1865(11, Part B):1718–32. Available from: https://www.sciencedirect.com/science/article/pii/S0167488918302490.
- Timothy KW, Bauer R, Larkin KA, Walsh EP, Abrams DJ, Gonzalez Corcia C, et al. A Natural History Study of Timothy Syndrome. Orphanet Journal of Rare Diseases. 2024; 19(1):433. Available from: https://doi.org/10.1186/s13023-024-03445-x.
- Krey JF, Pasca SP, Shcheglovitov A, Yazawa M, Schwemberger R, Rasmusson R, et al. Timothy Syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat Neurosci. 2013; 16(2):201–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568452/.
- Kishore MT, Udipi GA, Seshadri SP. Clinical Practice Guidelines for Assessment and Management of intellectual disability. Indian J Psychiatry. 2019; 61(Suppl 2):194–210. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345136/.

